Milan-based healthtech innovator Doctorsa has closed a €1 million seed funding round to enhance its digital healthcare platform for travellers. Led by PranaVentures with participation from Vento and 40Jemz Ventures, the capital will fuel its mission of providing seamless medical access. This funding supports the company's goal to make healthcare accessible to people away from home.
Addressing a Gap in Traveller Healthcare
International travellers often face hurdles when seeking medical care, including language barriers and navigating unfamiliar healthcare systems. Doctorsa addresses these challenges by providing timely support for common non-emergency health issues. The platform handles conditions like infections, respiratory problems, and other urgent care needs experienced abroad.
The service operates on a simple, on-demand model without requiring a subscription, making it highly accessible. Users describe their symptoms and are connected with a doctor for a video consultation within five minutes. Consultations are conducted in English, with competitive pricing starting from €20 per session.
Founded by Nadia Neytcheva and Francesco Maria Serino, the platform has demonstrated impressive traction. Operating as Doctorsa since 2023, it has already assisted over 250,000 travellers in three years. The company's network includes more than 550 doctors located across 40 different countries.
Strategic Vision and Technological Innovation
CEO Nadia Neytcheva emphasized the company's patient-centric philosophy, stating, "We think it's time the system adapted to people instead." The core objective is to integrate fast, trusted medical access seamlessly into every travel experience. This approach aims to eliminate the stress of finding care when things go wrong.
In line with its forward-thinking approach, Doctorsa is pioneering the use of agentic AI solutions in healthcare. The company developed a proprietary Agentic Booking infrastructure built on open-standard interfaces. This technology allows users to book medical consultations directly through their preferred AI assistant while maintaining control.
The company's rapid growth indicates a strong market demand for transparency, speed, and choice in a traditionally rigid sector. With new backing from PranaVentures, Doctorsa plans to accelerate the adoption of its model. This will be achieved through strategic partnerships with travel companies, insurers, and employers.
Investment Rationale and Expansion Plans
Sergio Scalzi of PranaVentures highlighted the company's strategic market position at the intersection of growing travel and telemedicine adoption. He praised the team's strong execution and distinctive international positioning developed in just a few years. This investment strengthens PranaVentures' commitment to the Future of Health vertical.
The newly acquired €1 million in capital will be deployed to consolidate Doctorsa's presence in existing markets. A primary objective is to accelerate its international expansion, with a significant focus on the United States. This market is important as US citizens already constitute 40 percent of the platform's patients.
A key component of the company's growth strategy involves the rollout of its business-to-business (B2B) offering. This service is tailored for travel operators, insurance companies, and corporations seeking to enhance their value propositions. Partners can integrate Doctorsa's global digital healthcare services into their customer or employee welfare programs.
This €1 million seed funding marks a pivotal moment for Doctorsa, empowering its mission to redefine healthcare for the modern traveller. By combining an accessible on-demand service with innovative AI technology, the company is poised for significant international growth. The investment validates its model and strengthens its potential to become an indispensable tool in the travel ecosystem.